FiercePharmaAsia—6 Dimensions’ investments; Sun’s branded drug nod; China’s cancer drug tariff
admin 23rd March 2018 Uncategorised 0China and U.S.-based 6 Dimensions Capital invest in several high-profile biotechs; Sun Pharma turns to specialty pharma with its newly FDA-approved psoriasis drug Ilumya; China plans to remove the tariff on anticancer drugs; plus more pharma industry news from Asia.
read more